Jonathan Craft

Translational scientist with extensive experience in NGS-based assays for molecular oncology, hereditary cancer diagnostics, and liquid biopsy development. Expertise in product design, assay development, and regulatory compliance: CLIA, CAP, ISO 15189, FDA, IVDR, and CLSI standards. Proven track record in biomarker discovery, analytical and clinical validation, and regulatory strategy to ensure the commercialization of high-quality assays that improve patient outcomes.

Over 14 year's experience in entire product lifecycle product development for hereditary oncology and liquid biopsy NGS testing. I've worked on the bend in R&D for Sanger Sequencing, NGS, Microarray, Cell Culture and qPCR.

B.S. in Biology from West Virginia University Institute of Technology and pursued Ph.D. in Molecular Biology at the University of Utah